For example, conjugates of GnRH analogs with chemotherapeutic drugs, delivery carriers, or imaging agents specifically deliver drugs or agents into GnRHR-positive cancer cells rather than GnRHR-negative cells (Shah et al., 2013; Emons et al., 2014; Taratula et al., 2015). The gene discussed is GNRHR; the disease is cancer.